Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Jared Kelly
Person

Jared Kelly

Tracked across 3 events · 19 articles · First seen Jun 02, 2026 · Last active Jul 21, 2026

Sentiment
10
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
4 0
Business
Oncolytics Biotech secures pelareorep patent
Impact: Jared Kelly, CEO of Oncolytics Biotech, commented on the importance of building a strong intellectual property estate for pelareorep's commercialization.
Jun 16, 2026 · 6 articles
2 30
Regulatory
FDA Fast Track for Pelareorep in Anal Cancer
Impact: As CEO, Jared Kelly announced the Fast Track designation and expressed confidence in the regulatory pathway. His leadership is central to the company's strategy.
Jul 20, 2026 · 6 articles
2 0
Business
Oncolytics Biotech appoints Glover, promotes McAdory
Impact: Jared Kelly>>>, CEO of Oncolytics Biotech>>>, expressed enthusiasm for the new appointments, highlighting their expected contributions to the company's growth.
Jun 02, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Jared Kelly live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.